Clinical Trial Update: Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

View source ↗

Summary

This clinical trial update describes the long-term follow-up of the Phase I/II infusion of RP-L102 in Fanconi Anemia. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia

Drugs mentioned

• RP-L102

Snippet

Sponsor: Rocket Pharmaceuticals Inc. | Conditions: Fanconi Anemia | Status: ENROLLING_BY_INVITATION